# Biomarkers in Patients With Metastatic Breast Cancer

> **NCT05871788** · — · NOT_YET_RECRUITING · sponsor: **Tunisian Association for Immuno-oncology Research** · enrollment: 1600 (estimated)

## Conditions studied

- Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia

## Interventions

- **DIAGNOSTIC_TEST:** identify biomarkers

## Key facts

- **NCT ID:** NCT05871788
- **Lead sponsor:** Tunisian Association for Immuno-oncology Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-06
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 1600 (ESTIMATED)
- **Last updated:** 2023-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05871788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05871788, "Biomarkers in Patients With Metastatic Breast Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05871788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*